Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
0 Pogledi
• 07/04/23
0
0
Ugraditi
administrator
Pretplatnici
Earn CME for related activities: https://www.naccme.com/oln
This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.
© 2018 NACCME, an HMP Company
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari